Accommodation and gastronomyYou are hereOur regionGeographical situationAccommodation and gastronomy
GateWest Switzerland is of course known for its offer of luxury hotels. Small inns, farmhouses and guest-houses also abound in varied landscapes, and their managers are always motivated by the desire to give you a hearty welcome.
Switzerland is quite cosmopolitan in matters of gastronomy. There are hundreds of restaurants (Switzerland has about 30,000 traditional public establishments of all kinds; there is one public establishment for an average of 250 inhabitants) that serve cooking from five continents.
The main cooking prepared in small inns, taverns, guest tables, farmhouses or larger restaurants is rather of French inspiration. Of course, GateWest Switzerland also relies on an important regional cooking tradition, with genuine, typical and delicious dishes that honour rural flavour.
For your pleasure, passing by markets or at producers, you will be able to discover a thousand traditional specialities, one more unique than the other, in each of the seven cantons of GateWest Switzerland.
On top of the numerous traditional or creative restaurants and cafés, motivated by the culture of “receiving well”, the region also has a high concentration of gastronomic restaurants, among which 45 restaurants have 1, 2 or 3 stars in the Michelin Guide. Gourmets will have a great time!
Medtech Innovation Event - Sept 4 - Swiss Innovation Park Biel/Bienne04.09.2017Swiss Medtech, be-advanced and Switzerland Innovation Park Biel/Bienne organise the 3rd matchmaking event solely for...
Welcome To Health ValleyBuilding on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Med Discovery SATherapeutics & Diagnostics, Proteins / PeptidesMed Discovery is a Swiss biopharmaceutical company dedicated to the discovery and the development of highly specific treatments for uro-genital cancers.
Our strategy is to develop protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways.
To achieve this we are leveraging a unique in-house expertise in kallikreins, the biggest class of human proteases, combined with an international network in clinical urology.
Our proprietary technology platform to produce protease inhibitors allows Med Discovery to target cancers or other diseases where there is a lack of specific treatment.
Using this approach, Med Discovery intends to become a leading research and development biotech company in the uro-genital field, developing products both in-house and with appropriate partners.